Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -0.12% 834.00p 834.00p 834.50p 834.50p 834.00p 834.00p 14,732 08:21:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 620.5 -70.6 3.9 213.8 3,231.17

Btg Share Discussion Threads

Showing 4976 to 4999 of 6175 messages
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older
DateSubjectAuthorDiscuss
09/11/2017
18:03
CT , why you so negative ? Did you short sell ? I am agree with bb that Madame should go with Rolf May be Varethena will be 200 mil ?
a1ord53
09/11/2017
17:41
And btw 750x20%=150 or 600p/share. Let's wait and see, but I have known this company for a very long time - going all the way back to 1992.
cockneytrader
09/11/2017
16:42
Time Price Volume Value Buy/Sell Type (key) 15:51 732.50p 1,363,000 £9,983,975 Buy NT 15:51 732.50p 1,363,000 £9,983,975 Buy NT
ashehzi
09/11/2017
12:51
Louise is good, CFO should go, but Louise is also part of the problem.
cockneytrader
09/11/2017
12:46
CS should have never been replaced as CFO. I have my own theories as why she was.
cockneytrader
09/11/2017
12:38
That predicted decline of 20% (since all this was announced) will come up all fast once we know HOW bad this whole thing has been, certainly come results and analysts Q&A. Longer term the story still exists, which is good. However, I said the CFO lost heart many years ago. He sold shares down and was going to resign at one stage, this doesn't help.
cockneytrader
08/11/2017
18:35
It will be roll down Tuesday , by the looks of it. Hopefully Louise resigns.
bargainbob
08/11/2017
16:30
Roll on Tuesday...let's get it over.
fhmktg
07/11/2017
09:33
As a long term holder who is doing very well from this speculative share there seems to be an over reaction to the Legal action decision which first came to light on 20th September 2017. 10 days before this the share price was at 705p on the 11 days preceding the announcement the price dropped to 665p on the day of the announcement. Since then it has climbed steadily with the implications of the judgement known to the market. The latest drop of around 6% puts the price back about 3 weeks. As this share does fluctuate between hard news there is nothing unusual. Given the changes in the company since I first invested I see the process as on going. The CEO is managing the process not the share price but if it rises to 786 I will have doubled my money ignoring the profits I have already banked. I think this team is quite visionary operating in a difficult industry so expect the odd b*lls up. IMHO
ugandalad
07/11/2017
07:48
Bring it on!
semper vigilans
07/11/2017
07:32
Ok where do we sign.
bargainbob
07/11/2017
07:16
OK!£10.50 and it's a deal!
fhmktg
07/11/2017
02:58
£9 a share they can have it.
bargainbob
06/11/2017
23:36
£12 a share and they can have it!
fhmktg
06/11/2017
17:19
Very poor show today. And these people pay themselves millions, and can't perform. This is not a one off, many millions down the drain in previous news flow, all home grown. I am afraid to have to inform you all that BTG is probably better off in foreign hands, we just don't seem to have the capacity for big business.
cockneytrader
06/11/2017
13:37
I am being writing here many years , that Dame and her Rolf just not good enough and should go. Penalty paid for Biocompatibles, wrong management build own sales Varethena team instead of licence or partner with big ones.Vistogard - lost deal. Although for today move is to blame insiders, who over bought on insiders news and sold of today scared to death .
a1ord53
06/11/2017
13:00
Investor Chronicle just posted update after this mornings announcements stating they believe shares undervalued and are stil buyers.!!
ugandalad
06/11/2017
12:23
I think the company has said there are approx 750k below the knee treatments in US. At $1.6k a treatment that's a market that's worth $1.2bn. So to be a $100m rev biz Varathena would need a 10% market share.
allonblack
06/11/2017
12:18
Allonblack, I take you use the product?
cockneytrader
06/11/2017
12:08
Max dosage is not a guide to how much gets used and shelf life is irrelevant. Typically the doctor will use 3-5ml and that's it. The can gets used over the day on several patients. 15ml would be used very rarely for above the knee main vein. The numbers you are quoting aren't relevant to the news this morning. Varithena may not succeed. But it will be doctors preferring laser treatment to foam. It will have nothing to do with the cost of the can or its shelf life.
allonblack
06/11/2017
11:59
The maximum number of treatments from one canister, in best case is 15 treatments at 3ml minimum uptake. In these clinics Varithena may be an option.
cockneytrader
06/11/2017
11:39
Varithena has never been up and running. Look at the pitiful revenues. One canister contains 45 ml of usable foam of which 15ml is the maximum permissible for one vein. Therefore one canister per three veins. That's $1000 of foam per treatment excluding all other costs. And btw, the canister has only a 30 day shelf life. Varithena has cost shareholders over £250 million to date and is most definitely not up and running.
cockneytrader
06/11/2017
11:19
Varithena is up and running again. I'm not sure where you get the view that its now a write off.Most treatments eg below the knee only need 2/3ml. Most people can be treated in this bracket. The issue is now whether Drs treat using laser or foam not Varithena specific. In fact doctors now have an incentive to use Varithena vs own foam as the fee is 10x higher. Varithena is now more likely to be a 100m biz again as a result of this pricing and def not a write off. The loss of Vistogard is a 2% downgrade to 2020 earnings that was priced in September. Right reaction is probably -4% today after +4% Friday and then higher.
allonblack
06/11/2017
10:54
It was said that to gain growth it needed a joint partnership. Louise will learn her lesson , just because you have a better mouse trap does not mean people will follow your path.
bargainbob
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older
Your Recent History
LSE
BTG
Btg
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190619 08:00:06